SCHEMBL20733063

SCHEMBL20733063

CN(C)c1ccc(-c2ccc3nccc(C(=N)N4CC[C@@H](O)C4)c3c2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 8/20 0.42
▸ CYP3A4 P08684 8/20 0.42
▸ CLK4 Q9HAZ1 6/20 0.42
▸ MAPK1 P28482 6/20 0.42
▸ HSD17B10 Q99714 5/20 0.42
▸ USP2 O75604 5/20 0.42
▸ LMNA P02545 4/20 0.42
▸ CYP2D6 P10635 6/20 0.41
▸ CYP2C19 P33261 6/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ MAPT P10636 2/20 0.41
▸ HPGD P15428 2/20 0.41
▸ ALDH1A1 P00352 5/20 0.40
▸ MEN1 O00255 4/20 0.40
▸ KMT2A Q03164 4/20 0.40
▸ TP53 P04637 2/20 0.40
▸ CASP1 P29466 2/20 0.40
▸ CASP7 P55210 1/20 0.40
▸ HIF1A Q16665 2/20 0.39
▸ SLC22A12 Q96S37 4/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22070421 1.00 CYP1A2 (0.42) CYP1A2CYP3A4CLK4MAPK1HSD17B10
SCHEMBL20732861 1.00 CYP1A2 (0.42) CYP1A2CYP3A4CLK4MAPK1HSD17B10
SCHEMBL22070420 0.88 KMT2A (0.43) CYP1A2CYP3A4CLK4MAPK1HSD17B10
SCHEMBL20732855 0.88 KMT2A (0.43) CYP1A2CYP3A4CLK4MAPK1HSD17B10
SCHEMBL20732919 0.88 KMT2A (0.43) CYP1A2CYP3A4CLK4MAPK1HSD17B10
SCHEMBL22113713 0.85 CYP1A2 (0.45) CYP1A2CYP3A4CLK4MAPK1HSD17B10
SCHEMBL22113889 0.74 CYP1A2 (0.45) CYP1A2CYP3A4CLK4MAPK1HSD17B10
SCHEMBL20732852 0.74 LMNA (0.55) CYP1A2CYP3A4CLK4MAPK1HSD17B10
SCHEMBL20732922 0.68 MAPKAPK2 (0.53) CYP1A2CYP3A4CLK4MAPK1HSD17B10
SCHEMBL20733070 0.66 CYP1A2 (0.57) CYP1A2CYP3A4CLK4MAPK1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3666770-A1 NOVEL HETEROCYCLIC COMPOUNDS AS CDK8/19 INHIBITORS Joint Stock Company "Biocad" (RU) 2020-06-17 — — EP claimed
EP-3666770-A1 NOVEL HETEROCYCLIC COMPOUNDS AS CDK8/19 INHIBITORS Joint Stock Company "Biocad" (RU) 2020-06-17 — — EP disclosed
EP-3666770-A1 NOVEL HETEROCYCLIC COMPOUNDS AS CDK8/19 INHIBITORS Joint Stock Company "Biocad" (RU) 2020-06-17 — — EP disclosed
WO-2019031990-A1 NOVEL HETEROCYCLIC COMPOUNDS AS CDK8/19 INHIBITORS ЗАКРЫТОЕ АКЦИОНЕРНОЕ ОБЩЕСТВО "БИОКАД" 2019-02-14 — — WO disclosed
Send feedback